Immune cells found to fuel colon cancer stem cells

May 8, 2014, University of Michigan Health System

A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells.

So finds a new study that is an international collaboration among researchers from the United States, China and Poland.

"If you want to control cancer stem cells through new therapies, then you need to understand what controls the cancer stem cells," says senior study author Weiping Zou, M.D., Ph.D., Charles B. de Nancrede Professor of surgery, immunology and biology at the University of Michigan Medical School.

Consider invasive Africanized honey bees. The worker honey bees are like the bulk majority of tumor cells while the is like the . The queen bee can repopulate an entire colony but survives on royal jelly. If you remove the royal jelly, the queen bee dies and the entire colony of invasive Africanized honey bees can be removed. Th22-derived IL-22 is the royal jelly.

Th22 is a subset of a type of immune cell called T-cells. Typically, T-cells are the soldiers of the immune system, killing off . In the case of , the researchers found, Th22 acts as a tumor helper, actually supporting the cells in becoming able to renew – one of the hallmarks of cancer stem cells.

The researchers discovered that an epigenetic factor called DOT1L is regulated by IL-22, contributing to the developing stem cell properties. High levels of DOT1L in patient tumor samples were tied to shorter survival. The researchers suggest DOT1L may be a marker for colon cancer progression, and that this pathway could potentially be targeted in new colon cancer treatments.

The researchers are now looking at potential drugs that might target this process directly. No specific therapies are currently available.

Tumor immunology and immunotherapy has become a hot research topic recently. Science named it the breakthrough of the year in 2013. Zou's group has been among the pioneers in understanding how the immune system plays a role in cancer.

Explore further: Some immune cells appear to aid cancer cell growth, study finds

More information: Paper: Immunity, Vol. 40, No. 5, May 15, 2014.

Related Stories

Some immune cells appear to aid cancer cell growth, study finds

September 5, 2013
The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.

Scientists discover endogenous dendritic cell-derived interleukin-27 promotes tumor growth

May 1, 2014
In a new report published in the Journal of Leukocyte Biology, scientists lay the groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive ...

New breast cancer stem cell findings explain how cancer spreads

January 14, 2014
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes ...

Researchers target cancer stem cells in malignant brain tumors

January 6, 2014
Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery identified immune system targets on cancer stem cells – cells from which malignant brain tumors are believed to originate ...

Immunogenic mutations in tumor genomes correlate with increased patient survival

April 29, 2014
Developing immunotherapies for cancer is challenging because of significant variability among tumors and diversity in human immune types. In a study published online today in Genome Research, researchers examined the largest ...

One cell type may quash tumor vaccines

April 28, 2014
Most cancer vaccines have not lived up to their promise in clinical trials. The reason, many researchers suspect, is that the immune cells that would help the body destroy the tumor – even those reactions boosted by cancer ...

Recommended for you

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.